Daimon Peter Simmons, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Interferon Type I | 4 | 2024 | 562 | 0.810 |
Why?
|
Macrophage Activation | 1 | 2022 | 553 | 0.640 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2018 | 32 | 0.620 |
Why?
|
Prothrombin Time | 1 | 2018 | 117 | 0.610 |
Why?
|
Partial Thromboplastin Time | 1 | 2018 | 204 | 0.590 |
Why?
|
Antiphospholipid Syndrome | 1 | 2018 | 165 | 0.540 |
Why?
|
ABO Blood-Group System | 2 | 2018 | 380 | 0.530 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2016 | 83 | 0.530 |
Why?
|
Histocompatibility Testing | 2 | 2023 | 712 | 0.520 |
Why?
|
Blood Group Incompatibility | 1 | 2015 | 135 | 0.460 |
Why?
|
Hemolysis | 1 | 2015 | 415 | 0.420 |
Why?
|
Toll-Like Receptor 9 | 2 | 2012 | 233 | 0.410 |
Why?
|
Toll-Like Receptor 2 | 2 | 2012 | 347 | 0.390 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2023 | 1349 | 0.360 |
Why?
|
Synovial Membrane | 2 | 2024 | 532 | 0.350 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2012 | 1435 | 0.350 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2020 | 63 | 0.320 |
Why?
|
Antigen Presentation | 2 | 2012 | 1251 | 0.320 |
Why?
|
Dendritic Cells | 4 | 2020 | 2747 | 0.280 |
Why?
|
Blood Grouping and Crossmatching | 2 | 2018 | 100 | 0.270 |
Why?
|
Inflammation | 2 | 2022 | 10773 | 0.240 |
Why?
|
Chemokine CXCL13 | 1 | 2024 | 59 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2024 | 286 | 0.220 |
Why?
|
Graft Rejection | 1 | 2016 | 4445 | 0.210 |
Why?
|
Receptors, Glucocorticoid | 1 | 2024 | 305 | 0.210 |
Why?
|
Immunoglobulin M | 3 | 2023 | 1527 | 0.200 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2024 | 220 | 0.200 |
Why?
|
Fibroblasts | 2 | 2024 | 4141 | 0.200 |
Why?
|
Kidney Transplantation | 1 | 2016 | 4234 | 0.190 |
Why?
|
Receptors, Death Domain | 1 | 2020 | 31 | 0.180 |
Why?
|
Mycobacterium tuberculosis | 2 | 2012 | 1914 | 0.170 |
Why?
|
Alleles | 3 | 2023 | 6863 | 0.170 |
Why?
|
Isoantibodies | 1 | 2023 | 674 | 0.160 |
Why?
|
beta 2-Glycoprotein I | 1 | 2018 | 28 | 0.160 |
Why?
|
Antibodies, Anticardiolipin | 1 | 2018 | 62 | 0.160 |
Why?
|
Antigens, Human Platelet | 1 | 2018 | 41 | 0.150 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1136 | 0.150 |
Why?
|
Adipocytes | 1 | 2024 | 1194 | 0.150 |
Why?
|
Paraproteinemias | 1 | 2020 | 248 | 0.140 |
Why?
|
Natural Killer T-Cells | 1 | 2020 | 322 | 0.140 |
Why?
|
Immunomagnetic Separation | 1 | 2016 | 79 | 0.140 |
Why?
|
Hydrocortisone | 1 | 2024 | 1819 | 0.140 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3156 | 0.130 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4544 | 0.130 |
Why?
|
Arthritis, Rheumatoid | 2 | 2022 | 3763 | 0.120 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2016 | 303 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2161 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2022 | 4575 | 0.120 |
Why?
|
Medical Order Entry Systems | 1 | 2020 | 521 | 0.120 |
Why?
|
Tissue Transplantation | 1 | 2015 | 128 | 0.120 |
Why?
|
Cross Reactions | 1 | 2016 | 817 | 0.120 |
Why?
|
Cost Savings | 1 | 2020 | 913 | 0.120 |
Why?
|
Interleukin-1beta | 1 | 2020 | 999 | 0.120 |
Why?
|
Interleukin-17 | 1 | 2020 | 912 | 0.110 |
Why?
|
Lipopeptides | 2 | 2012 | 71 | 0.110 |
Why?
|
Cells, Cultured | 3 | 2022 | 18965 | 0.110 |
Why?
|
Cross-Priming | 2 | 2010 | 76 | 0.110 |
Why?
|
Cell Transplantation | 1 | 2015 | 472 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2024 | 4369 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2024 | 4352 | 0.100 |
Why?
|
Models, Immunological | 1 | 2015 | 513 | 0.100 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2012 | 221 | 0.100 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2012 | 76 | 0.100 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2024 | 2155 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2244 | 0.100 |
Why?
|
Acute Disease | 1 | 2022 | 7237 | 0.090 |
Why?
|
Toll-Like Receptors | 2 | 2012 | 589 | 0.090 |
Why?
|
Genes, MHC Class II | 1 | 2012 | 434 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2449 | 0.090 |
Why?
|
Toll-Like Receptor 7 | 1 | 2012 | 177 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2416 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 1 | 2020 | 1175 | 0.090 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22169 | 0.090 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4243 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2898 | 0.080 |
Why?
|
Crohn Disease | 1 | 2022 | 2279 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
Signal Transduction | 4 | 2024 | 23445 | 0.080 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2012 | 621 | 0.080 |
Why?
|
Ovalbumin | 1 | 2010 | 677 | 0.080 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2010 | 779 | 0.080 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 891 | 0.080 |
Why?
|
Interferon-beta | 1 | 2010 | 345 | 0.080 |
Why?
|
Antibodies | 1 | 2016 | 2418 | 0.080 |
Why?
|
Mycobacterium bovis | 1 | 2008 | 147 | 0.070 |
Why?
|
Histocompatibility Antigens | 1 | 2009 | 464 | 0.070 |
Why?
|
Phagosomes | 1 | 2009 | 199 | 0.070 |
Why?
|
Endocytosis | 1 | 2012 | 957 | 0.070 |
Why?
|
BCG Vaccine | 1 | 2010 | 369 | 0.070 |
Why?
|
Chronic Disease | 1 | 2022 | 9318 | 0.070 |
Why?
|
Tissue Donors | 1 | 2016 | 2331 | 0.070 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 1036 | 0.070 |
Why?
|
Software | 1 | 2020 | 4434 | 0.070 |
Why?
|
Interferon-alpha | 1 | 2010 | 921 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2008 | 412 | 0.060 |
Why?
|
CpG Islands | 1 | 2010 | 1230 | 0.060 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2024 | 29 | 0.060 |
Why?
|
Thrombosis | 1 | 2018 | 2942 | 0.060 |
Why?
|
Membrane Glycoproteins | 2 | 2012 | 3702 | 0.060 |
Why?
|
Humans | 17 | 2024 | 761504 | 0.050 |
Why?
|
Antigens, Bacterial | 1 | 2009 | 1155 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3810 | 0.050 |
Why?
|
Cell Differentiation | 3 | 2024 | 11528 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2023 | 14666 | 0.050 |
Why?
|
Mice | 6 | 2024 | 81525 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2024 | 14414 | 0.050 |
Why?
|
Trans-Activators | 1 | 2012 | 2856 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6534 | 0.050 |
Why?
|
Adipogenesis | 1 | 2024 | 368 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 629 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2009 | 1390 | 0.040 |
Why?
|
Limit of Detection | 1 | 2021 | 273 | 0.040 |
Why?
|
Chemokine CXCL2 | 1 | 2020 | 106 | 0.040 |
Why?
|
Transcription Factors | 1 | 2020 | 12128 | 0.040 |
Why?
|
Chemokine CXCL1 | 1 | 2020 | 101 | 0.040 |
Why?
|
Caspase 8 | 1 | 2020 | 190 | 0.040 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2020 | 138 | 0.040 |
Why?
|
Chemotactic Factors | 1 | 2020 | 197 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 978 | 0.040 |
Why?
|
Caspase 1 | 1 | 2020 | 225 | 0.040 |
Why?
|
Arthritis | 1 | 2024 | 680 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2020 | 254 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 974 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2023 | 1870 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 943 | 0.040 |
Why?
|
Chemokines, CXC | 1 | 2020 | 422 | 0.040 |
Why?
|
Animals | 7 | 2024 | 168459 | 0.040 |
Why?
|
Immunoassay | 1 | 2021 | 745 | 0.040 |
Why?
|
Synovial Fluid | 1 | 2020 | 393 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1328 | 0.040 |
Why?
|
Antigens | 1 | 2023 | 1443 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5796 | 0.040 |
Why?
|
Female | 6 | 2024 | 392644 | 0.030 |
Why?
|
Efficiency | 1 | 2020 | 476 | 0.030 |
Why?
|
Pregnancy | 1 | 2018 | 29874 | 0.030 |
Why?
|
Cell Line | 1 | 2010 | 15601 | 0.030 |
Why?
|
Genome, Human | 2 | 2020 | 4425 | 0.030 |
Why?
|
Autoimmunity | 1 | 2023 | 1356 | 0.030 |
Why?
|
Tuberculosis | 1 | 2008 | 2017 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7856 | 0.030 |
Why?
|
Inflammasomes | 1 | 2020 | 526 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1400 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1330 | 0.030 |
Why?
|
Phenotype | 1 | 2012 | 16591 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11903 | 0.030 |
Why?
|
Adult | 3 | 2022 | 221177 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2018 | 1742 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3429 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2570 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.020 |
Why?
|
Erythrocytes | 1 | 2018 | 2413 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9420 | 0.020 |
Why?
|
Immunodominant Epitopes | 1 | 2009 | 239 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3639 | 0.020 |
Why?
|
Blood Platelets | 1 | 2018 | 2479 | 0.020 |
Why?
|
Immunity | 1 | 2012 | 996 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2012 | 1756 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15266 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2008 | 964 | 0.020 |
Why?
|
Male | 4 | 2024 | 360804 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15732 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9486 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1459 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10209 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2416 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14031 | 0.010 |
Why?
|
Aged | 2 | 2021 | 169289 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4358 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 220895 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2009 | 4580 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58976 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59243 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80636 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 88319 | 0.010 |
Why?
|